LL6653-1
Expected range of benefit
Active
Basic Properties
- OID
- 1.3.6.1.4.1.12009.10.1.5470
- Name
- Expected range of benefit
- Description
- 11% decrease in risk 30% decrease in risk 45% decrease in risk 95% decrease in risk
- LOINCs using this list
- 1
Answer List
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| 11% decrease in risk | LA34245-3 | ||
| 30% decrease in risk | LA34246-1 | ||
| 45% decrease in risk | LA34247-9 | ||
| 95% decrease in risk | LA34248-7 |
LOINC terms using this Answer List
| 105496-4 | A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50% |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LL6653-1 - ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LL6653-1 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LL6653-1
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright